Pulse Therapeutics Inc
Advertisement
Photos
Accuronix is a biopharmaceutical company based in Saint Louis, MO, focused on developing innovative cancer therapies that selectively target tumor cells, enhancing treatment efficacy while minimizing toxicity. Their lead candidate, ACXT-3102, is a novel small molecule drug conjugate designed for preclinical application against pancreatic adenocarcinoma and other rare tumors, leveraging a unique delivery mechanism that promotes cancer cell death through apoptosis and ferroptosis.
Committed to addressing significant unmet needs in oncology, Accuronix is expanding its library of receptor ligands to improve drug targeting strategies, particularly against the -2 receptor which is overexpressed in various cancers. The company's mission centers on partnering with academic and research institutions to advance its groundbreaking therapies toward regulatory designations and eventual clinical application.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.
Advertisement
